List of Tables
Table 1. Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of 350 Mg
Table 3. Key Players of 313 Mg
Table 4. Global Acute Hepatic Porphyria Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Acute Hepatic Porphyria Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Acute Hepatic Porphyria Drug Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Acute Hepatic Porphyria Drug Market Share by Region (2020-2025)
Table 8. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Acute Hepatic Porphyria Drug Market Share by Region (2026-2031)
Table 10. Acute Hepatic Porphyria Drug Market Trends
Table 11. Acute Hepatic Porphyria Drug Market Drivers
Table 12. Acute Hepatic Porphyria Drug Market Challenges
Table 13. Acute Hepatic Porphyria Drug Market Restraints
Table 14. Global Acute Hepatic Porphyria Drug Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Acute Hepatic Porphyria Drug Market Share by Players (2020-2025)
Table 16. Global Top Acute Hepatic Porphyria Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Hepatic Porphyria Drug as of 2024)
Table 17. Ranking of Global Top Acute Hepatic Porphyria Drug Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Acute Hepatic Porphyria Drug Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Acute Hepatic Porphyria Drug, Headquarters and Area Served
Table 20. Global Key Players of Acute Hepatic Porphyria Drug, Product and Application
Table 21. Global Key Players of Acute Hepatic Porphyria Drug, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Hepatic Porphyria Drug Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2020-2025)
Table 25. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2026-2031)
Table 27. Global Acute Hepatic Porphyria Drug Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Acute Hepatic Porphyria Drug Revenue Market Share by Application (2020-2025)
Table 29. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Acute Hepatic Porphyria Drug Revenue Market Share by Application (2026-2031)
Table 31. North America Acute Hepatic Porphyria Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Acute Hepatic Porphyria Drug Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Acute Hepatic Porphyria Drug Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Acute Hepatic Porphyria Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Acute Hepatic Porphyria Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Acute Hepatic Porphyria Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Acute Hepatic Porphyria Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Acute Hepatic Porphyria Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Acute Hepatic Porphyria Drug Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Acute Hepatic Porphyria Drug Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Alnylam Pharmaceuticals Company Details
Table 47. Alnylam Pharmaceuticals Business Overview
Table 48. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Product
Table 49. Alnylam Pharmaceuticals Revenue in Acute Hepatic Porphyria Drug Business (2020-2025) & (US$ Million)
Table 50. Alnylam Pharmaceuticals Recent Development
Table 51. Recordati Rare Diseases Company Details
Table 52. Recordati Rare Diseases Business Overview
Table 53. Recordati Rare Diseases Acute Hepatic Porphyria Drug Product
Table 54. Recordati Rare Diseases Revenue in Acute Hepatic Porphyria Drug Business (2020-2025) & (US$ Million)
Table 55. Recordati Rare Diseases Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
Table 59. Authors List of This Report
List of Figures
Figure 1. Acute Hepatic Porphyria Drug Picture
Figure 2. Global Acute Hepatic Porphyria Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Acute Hepatic Porphyria Drug Market Share by Type: 2024 VS 2031
Figure 4. 350 Mg Features
Figure 5. 313 Mg Features
Figure 6. Global Acute Hepatic Porphyria Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Acute Hepatic Porphyria Drug Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Others Case Studies
Figure 12. Acute Hepatic Porphyria Drug Report Years Considered
Figure 13. Global Acute Hepatic Porphyria Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Acute Hepatic Porphyria Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Acute Hepatic Porphyria Drug Market Share by Region: 2024 VS 2031
Figure 16. Global Acute Hepatic Porphyria Drug Market Share by Players in 2024
Figure 17. Global Top Acute Hepatic Porphyria Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Hepatic Porphyria Drug as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Acute Hepatic Porphyria Drug Revenue in 2024
Figure 19. North America Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Acute Hepatic Porphyria Drug Market Share by Country (2020-2031)
Figure 21. United States Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Acute Hepatic Porphyria Drug Market Share by Country (2020-2031)
Figure 25. Germany Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Acute Hepatic Porphyria Drug Market Share by Region (2020-2031)
Figure 33. China Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Acute Hepatic Porphyria Drug Market Share by Country (2020-2031)
Figure 41. Mexico Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Acute Hepatic Porphyria Drug Market Share by Country (2020-2031)
Figure 45. Turkey Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Acute Hepatic Porphyria Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Alnylam Pharmaceuticals Revenue Growth Rate in Acute Hepatic Porphyria Drug Business (2020-2025)
Figure 49. Recordati Rare Diseases Revenue Growth Rate in Acute Hepatic Porphyria Drug Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
